Biblio
Identification of novel myelin repair drugs by modulation of oligodendroglial differentiation competence. EBioMedicine. 2021;65:103276.
Current therapeutic landscape in multiple sclerosis: an evolving treatment paradigm. Curr Opin Neurol. 2019.
. Optic neuritis as a phase 2 paradigm for neuroprotection therapies of multiple sclerosis: update on current trials and perspectives. Curr Opin Neurol. 2016.
. Recent achievements in stem cell-mediated myelin repair. Curr Opin Neurol. 2016.
.